Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised study of oral cow's milk immunotherapy combined with sublingual immunotherapy in milk allergy
jRCT1031240155Not yet recruiting
- Start
- Jun 2024
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised trial of cow's milk allergen in cow's milk protein allergy (CMPA) (2 arms), sponsored by none. Primary endpoint: Negative rate of 25 mL oral challenge test (2nd time). Planned start Jun 2024; status: not yet recruiting.
02
Drugs
cow's milk allergen
03
Conditions
cow's milk protein allergy (CMPA)
Beyond the preview
Go deeper on jRCT1031240155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240155.